Objective To investigate independent influencing factors of colorectal adenomas (CRA) in patients with type 2 diabetes mellitus (T2DM) and to establish the risk prediction model. Methods Patients with T2DM undergoing colonoscopy were divided into the adenoma group (n=145, pathologically diagnosed as CRA) and the control group (n=174, without abnormal colorectal mucosa). Age, sex, body mass index (BMI) and diabetes course, history of hypertension, diabetic peripheral neuropathy, fatty liver, gastrointestinal symptoms, metformin and insulin use in recent 5 years, Helicobacter pylori (Hp) infection, smoking history, drinking history and fecal occult blood were compared between the two groups. Laboratory data were also compared between the two groups, including tumor abnormal protein (TAP), glycosylated hemoglobin (HbA1c), insulin resistance index (HOMA-IR), serum total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), uric acid (UA) and vitamin D3 levels. Multivariate Logistic regression was used to determine the independent risk factors for CRA in T2DM patients, and a new combined predictor was constructed (Lcombined). The combined prediction value of Lcombined was evaluated by ROC curve, and the fit degree was evaluated by Hosmer-Lemeshow test. Results In the adenoma group, age, BMI, male, history of hypertension, history of smoking, history of drinking, positive proportion of Hp, positive proportion of stool occult blood, HbA1c, TG, TAP and HOMA-IR were significantly higher than those in the control group. The proportion of metformin use and vitamin D3 levels were lower in the adenoma group than those in the control group (P<0.05). Multivariate Logistic regression showed that the increased age, BMI, TAP, TG, smoking history, positive Hp and positive occult blood were independent risk factors for CRA in T2DM patients, while metformin was an independent protective factor (P<0.05). ROC curve showed that the AUC of Lcombined was 0.815 (95%CI: 0.768-0.862, P<0.01), and Hosmer-Lemeshow test showed a good fit of the risk model (χ2=10.249, P=0.248). Conclusion The combined predictors of age, BMI, TAP, TG, smoking history, Hp infection, fecal occult blood and metformin use are effective in predicting the risk of colorectal adenoma in patients with T2DM.